AESTHETIC NEWSAESTHETIC NEWS

WASHINGTON, July 13, 2023 (Newswire.com)
–
The Calorie Control Council, an international association representing the low-calorie food and beverage industry, supports the World Health Organization’s (WHO) findings regarding the safety of aspartame, that aligns with more than 90 credible global scientific and regulatory food agencies that have extensively reviewed aspartame and determined it is safe.

JECFA is charged by the WHO to evaluate ingredients like aspartame and determine their safety. After conducting a thorough re-assessment, JECFA concluded there are no concerns regarding adverse effects of consuming aspartame at current levels and reaffirmed the acceptable daily intake level (ADI), underscoring its previous conclusion that aspartame is safe.  

“The JECFA ruling not only confirms the four decades of science concluding aspartame is safe but also provides real-life ‎context around the safe consumption of this ingredient,” said Robert Rankin, President, Calorie Control Council. “In order to reach JECFA’s conservative ADI estimates, the average 150 lb. person would need to consume about 14 12-oz cans of diet beverages or about 74 packets of aspartame-containing tabletop sweetener every day over the course of their life to raise any safety concern. Obviously, that level of consumption is not realistic, recommended, nor is it ‎aligned with the intended use of these ingredients.”  

“Consumers have a strong desire for reliable and science-based information and JECFA’s review reaffirms the overwhelming body of evidence that confirms aspartame is safe. To assert otherwise is misleading, inaccurate, and fearmongering to the nearly 540 million people globally living with diabetes and millions of others managing their body weight who rely on and/or chose products that contain low- and no-calorie sweeteners such as aspartame,” continued Rankin.  

Consumers who look to low- and no-calorie sweeteners – including aspartame – for managing sugar and calorie reduction can continue to feel comfortable knowing it has been proven a safe and effective choice based on the findings of global health organizations which review the relevant scientific evidence regularly. 

### 

About the Calorie Control Council

The Calorie Control Council, established in 1966, is an international association representing the low- and reduced-calorie food and beverage industry. Today it represents manufacturers and suppliers of low-, no- and reduced-calorie foods and beverages, including manufacturers and suppliers of more than two dozen different alternative sweeteners, dietary fibers, and other low-calorie, dietary ingredients. More at caloriecontrol.org.  

Contact Information:

Robin Applebaum

[email protected]

678.303.2980

Original Source:

The Calorie Control Council Comments on the World Health Organization’s Review of the Safety of Aspartame

Neuma Develops Disinfecting Cap That Mechanically Cannot Be Used More Than Once

Neuma Innovations
Neuma Innovations Logo

PALO ALTO, Calif., July 11, 2023 (Newswire.com)
–
Neuma Innovations^TM, creator of the original Neuma Clamp^TM that deters and detects central line abuse by IVDU (intravenous drug using) patients, today announced the development of a new disinfecting cap that prevents reuse and is tamper-evident.

“We’ve been working closely with infusion professionals since 2015 to design solutions to problems associated with central line blood infections. We learned that about 28% of caregivers use the same disinfecting cap more than once, which obviously compromises the caps’ effectiveness. Our team set out to design a simple device that, because it can’t be reattached after the first use, dramatically improves compliance,” said Hal Rucker, President of Neuma Innovations. “The added benefit is that our cap also protects lines from patients who use their lines to self-inject illicit drugs.”

NO CHANGES TO WORKFLOWS

The Neuma Cap^TM disinfects, approaches 100% compliance, minimizes the harmful consequences of abuse by IVDU patients, facilitates the discharge to SNF and OPAT care, and fits seamlessly into existing workflows.

“The Neuma Cap genuinely ensures the enforcement of single-use protocols while its price point remains on par with comparable alternatives,” said Amy Duncan, Director of Business Development. “The ingenuity of Neuma’s product lies in its indistinguishable resemblance to conventional disinfecting caps without requiring any changes in workflow. From the perspective of clinicians, the Neuma Cap is a frictionless industry disrupter for optimal patient care.”

About Neuma Innovations

Neuma Innovations develops simple medical products to solve complex medical problems.

Neuma Caps and Neuma Clamps are patent-protected. Neuma, Neuma Innovations, Neuma Clamp, Neuma Central Line Protection Clamp, Neuma Cap, and Neuma Disinfecting Cap are trademarks of Neuma Innovations, LLC. All Rights Reserved. 

Copyright © 2023 Neuma Innovations LLC

Contact Information:

Hal Rucker

President

[email protected]

(650) 759-1203

Original Source:

Neuma Innovations’ Single-Use IV Disinfecting Cap Improves CLABSI Prevention and Deters Central Line Abuse by IVDU Patients

Enhanced Revenue Integrity offering strengthens audits, denials management, clinical documentation improvement solutions, and coder education to improve healthcare systems’ financial wellness.

AQuity Logo
AQuity Logo

CARY, N.C., July 11, 2023 (Newswire.com)
–
AQuity Solutions, an industry-leading, tech-enabled Clinical Documentation Capture, Medical Coding, and Mid-Revenue Cycle solution supplier for healthcare provider organizations, announced the launch of its Revenue Integrity portfolio. The solutions include Claim Denial & Appeals Management, Coding Audits & Record Analysis, Claim & Edit Remediation, Clinical Documentation Improvement, and Medical Coding Education & Training services.

The highly customizable set of offerings drive revenue cycle quality and productivity, allowing hospitals, clinics, and physician practices to meet and exceed their quality benchmarks through strengthened documentation capture details, improved coding accuracy, and payer-specific claim preparations to solidify accurate revenue while ensuring compliance. AQuity’s unique consultative approach helps manage risks and improve quality.

“Our Revenue Integrity solutions positively impact our client’s financial success through our team of experienced consultants in over 30 specialties, including Cardiovascular Interventional Radiology (CVIR) and other complex sub-specialties,” noted Susan Gatehouse, AQuity’s VP of Revenue Integrity and RHIT, CCS, and ICD-10 CM/PCS AHIMA Certified Trainer. “AQuity drives revenue success by applying detailed coding, charging, billing assessments, claim auditing, denial management, and multifaceted education strategies.” 

“With increased financial pressures and growing regulatory scrutiny for all provider organizations, AQuity’s Revenue Integrity solutions ensure compliance and financial performance,” added Kashyap Joshi, AQuity’s CEO. “Our commitment to expand our Revenue Integrity offerings is in direct response to market needs and our commitment to help AQuity clients overcome their most challenging issues related to the revenue cycle.” 

About AQuity

Headquartered in Cary, NC, AQuity provides solutions for 21 of the Top 25 and over half of the Top 250 Health Systems in the United States. AQuity employs over 7,500 virtual scribe and medical transcription document capture specialists, medical coders, and revenue integrity specialists in multiple specialties across the United States, India, Australia, Canada, and the U.K. With over 40 years of experience in solutions for healthcare, AQuity is recognized year after year by KLAS and Black Book as a leading vendor in multiple disciplines. AQuity is privately held. https://aquitysolutions.com. 

Contact Information:

Dale Kivi

Senior Director of Communications

[email protected]

804.339.9017

Original Source:

AQuity Broadens Its Portfolio With Launch of Revenue Integrity Solutions